Publication and clinical trial evidence

PubMed publication counts and ClinicalTrials.gov registered studies for each exerkine, from the February 2026 snapshot.

—Exerkinesin this selection
—PublicationsName in title or abstract
—Therapeutic shareMention “therapeutic” or “therapy”
—Registered clinical trials

Publications per exerkine

PubMed publications with the exerkine’s name in the title or abstract, split by whether they also mention “therapeutic” or “therapy”. Sorted by total.

Therapeutic mentionOther publications
Show data table

Share of publications that mention therapeutic use

Share of each exerkine’s publications that also mention “therapeutic” or “therapy”. This keyword-based measure indicates how much of the literature on an exerkine discusses therapeutic use.

Show data table

Publications and clinical trials

Each dot is an exerkine: publications on the horizontal axis and registered clinical trials on the vertical axis, both on logarithmic scales. The shade shows the translational tier.

Tier 1Tier 2Tier 3Tier 4
Show data table

Clinical trials by phase

Registered studies on ClinicalTrials.gov that mention each exerkine, by phase. Studies registered without a phase (mostly observational) are not shown, so bars can be shorter than the trial totals above.

Early phase 1Phase 1Phase 2Phase 3Phase 4Not applicable
Show data table

All studies by phase

All studies in the selection that list a phase. A study that mentions two exerkines is counted for each, so totals can exceed the number of distinct trials.

Show data table

Counts are keyword-based and come from the February 2026 snapshot; see how the evidence was collected. Download the numbers as CSV or JSON.